Gan & Lee Pharmaceuticals
SSE:603087

Watchlist Manager

Gan & Lee Pharmaceuticals

SSE:603087

Watchlist

Dividends

Discount Rate

Price: 44.81 CNY -4.7% Market Closed

Market Cap: 26.5B CNY

Have any thoughts about
Gan & Lee Pharmaceuticals?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 44.81 CNY

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

Alert

Gan & Lee Pharmaceuticals

44.81

-2.21 (-4.7%)

52 Week Range	33.1 59.6
Price Target

We'll email you a reminder when the closing price reaches CNY.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Gan & Lee Pharmaceuticals

What unique competitive advantages
does Gan & Lee Pharmaceuticals hold over its rivals?

What risks and challenges
does Gan & Lee Pharmaceuticals face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Gan & Lee Pharmaceuticals.

What unique competitive advantages
does Gan & Lee Pharmaceuticals hold over its rivals?

What risks and challenges
does Gan & Lee Pharmaceuticals face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Gan & Lee Pharmaceuticals.

Provide P/S
for Gan & Lee Pharmaceuticals.

Provide P/E
for Gan & Lee Pharmaceuticals.

Provide P/OCF
for Gan & Lee Pharmaceuticals.

Provide P/FCFE
for Gan & Lee Pharmaceuticals.

Provide P/B
for Gan & Lee Pharmaceuticals.

Provide EV/S
for Gan & Lee Pharmaceuticals.

Provide EV/GP
for Gan & Lee Pharmaceuticals.

Provide EV/EBITDA
for Gan & Lee Pharmaceuticals.

Provide EV/EBIT
for Gan & Lee Pharmaceuticals.

Provide EV/OCF
for Gan & Lee Pharmaceuticals.

Provide EV/FCFF
for Gan & Lee Pharmaceuticals.

Provide EV/IC
for Gan & Lee Pharmaceuticals.

Show me price targets
for Gan & Lee Pharmaceuticals made by professional analysts.

What are the Revenue projections
for Gan & Lee Pharmaceuticals?

How accurate were the past Revenue estimates
for Gan & Lee Pharmaceuticals?

What are the Net Income projections
for Gan & Lee Pharmaceuticals?

How accurate were the past Net Income estimates
for Gan & Lee Pharmaceuticals?

What are the EPS projections
for Gan & Lee Pharmaceuticals?

How accurate were the past EPS estimates
for Gan & Lee Pharmaceuticals?

What are the EBIT projections
for Gan & Lee Pharmaceuticals?

How accurate were the past EBIT estimates
for Gan & Lee Pharmaceuticals?

Compare the revenue forecasts
for Gan & Lee Pharmaceuticals with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Gan & Lee Pharmaceuticals and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Gan & Lee Pharmaceuticals against its competitors.

Analyze the profit margins
(gross, operating, and net) of Gan & Lee Pharmaceuticals compared to its peers.

Compare the P/E ratios
of Gan & Lee Pharmaceuticals against its peers.

Discuss the investment returns and shareholder value creation
comparing Gan & Lee Pharmaceuticals with its peers.

Analyze the financial leverage
of Gan & Lee Pharmaceuticals compared to its main competitors.

Show all profitability ratios
for Gan & Lee Pharmaceuticals.

Provide ROE
for Gan & Lee Pharmaceuticals.

Provide ROA
for Gan & Lee Pharmaceuticals.

Provide ROIC
for Gan & Lee Pharmaceuticals.

Provide ROCE
for Gan & Lee Pharmaceuticals.

Provide Gross Margin
for Gan & Lee Pharmaceuticals.

Provide Operating Margin
for Gan & Lee Pharmaceuticals.

Provide Net Margin
for Gan & Lee Pharmaceuticals.

Provide FCF Margin
for Gan & Lee Pharmaceuticals.

Show all solvency ratios
for Gan & Lee Pharmaceuticals.

Provide D/E Ratio
for Gan & Lee Pharmaceuticals.

Provide D/A Ratio
for Gan & Lee Pharmaceuticals.

Provide Interest Coverage Ratio
for Gan & Lee Pharmaceuticals.

Provide Altman Z-Score Ratio
for Gan & Lee Pharmaceuticals.

Provide Quick Ratio
for Gan & Lee Pharmaceuticals.

Provide Current Ratio
for Gan & Lee Pharmaceuticals.

Provide Cash Ratio
for Gan & Lee Pharmaceuticals.

What is the historical Revenue growth
over the last 5 years for Gan & Lee Pharmaceuticals?

What is the historical Net Income growth
over the last 5 years for Gan & Lee Pharmaceuticals?

What is the current Free Cash Flow
of Gan & Lee Pharmaceuticals?

Discuss the annual earnings per share (EPS)
trend over the past five years for Gan & Lee Pharmaceuticals.

P/B
Price to Book Value

2.5

Current

2.4

Median

2.5

Industry

Higher than median

Lower than industry value

Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.

P/B

2.5

Market Cap

26.9B CNY

Book Value of Equity

11B CNY

All Countries

Forward Multiples

			Market Cap	P/B
CN		Gan & Lee Pharmaceuticals SSE:603087	26.9B CNY	2.5
FR		Pharnext SCA OTC:PNEXF	6T USD	-186 195.9
US		Abbvie Inc NYSE:ABBV	312.7B USD	51.8
US		Amgen Inc NASDAQ:AMGN	158.3B USD	21
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	116.2B USD	7.4
US		Gilead Sciences Inc NASDAQ:GILD	112.4B USD	6.1
US	E	Epizyme Inc F:EPE	94.1B EUR	-4 835
AU		CSL Ltd ASX:CSL	133.6B AUD	5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	81.3B USD	2.8
US	S	Seagen Inc F:SGT	39.3B EUR	16.1
NL		argenx SE XBRU:ARGX	34.8B EUR	8.5


CN		Gan & Lee Pharmaceuticals SSE:603087	Average P/B: 13.5 2.5
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -186 195.9
US		Abbvie Inc NYSE:ABBV	51.8
US		Amgen Inc NASDAQ:AMGN	21
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	7.4
US		Gilead Sciences Inc NASDAQ:GILD	6.1
US	E	Epizyme Inc F:EPE	Negative Multiple: -4 835
AU		CSL Ltd ASX:CSL	5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	2.8
US	S	Seagen Inc F:SGT	16.1
NL		argenx SE XBRU:ARGX	8.5

P/B Forward Multiples

Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/B

N/A

2-Years Forward

P/B

N/A

3-Years Forward

P/B

N/A

Gan & Lee Pharmaceuticals
SSE:603087

P/B
Price to Book Value

P/B Forward Multiples

See Also

Company

Help

Tools

Stocks

Gan & Lee Pharmaceuticals SSE:603087

P/B Price to Book Value

P/B Forward Multiples

See Also

Company

Help

Tools

Stocks

Gan & Lee Pharmaceuticals
SSE:603087

P/B
Price to Book Value